Tirzepatide
A novel dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist.
Research Use Only. This product is intended for laboratory research purposes only and is not for human consumption. Not for sale to minors.
Product Description
Tirzepatide is a novel dual GIP and GLP-1 receptor agonist. It is a 39-amino acid synthetic peptide that activates both incretin hormone receptors simultaneously. Research has investigated its effects on glycemic control, body weight, and metabolic parameters.
Research Information
Research on tirzepatide has focused on its unique dual-agonist mechanism. Studies suggest simultaneous activation of both GIP and GLP-1 receptors may produce additive or synergistic effects on insulin secretion, glucagon suppression, and appetite regulation.
Dosage Guidance
Research protocols begin with lower doses and escalate over time. Standard vials contain 5mg lyophilized powder. All dosing information is for research reference only.
